Trending...
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
RESEARCH TRIANGLE PARK, N.C., July 16, 2021 /PRNewswire/ -- The U.S. Surgeon General has released a new Advisory proclaiming that the spread of misinformation -- in the context of the COVID-19 pandemic -- is a serious public health threat. Brian Southwell, Ph.D., is an expert on the topic of misinformation and how it spreads at RTI International, a nonprofit research institute. He is available for media interviews and can speak to why misinformation occurs, how to combat it and provide insights on improving communication channels to prevent another 'info-demic' from occurring in the future.
Dr. Southwell has served as a key resource throughout the COVID-19 pandemic to help inform media outlets and the public on what misinformation is and how to address it. He has dedicated parts of his decades-long career to investigating the public understanding and misunderstanding of science, which has contributed to the spread of misinformation throughout the COVID-19 pandemic.
More on ncarol.com
Dr. Southwell is senior director of the Science in the Public Sphere program at RTI. He also serves as a faculty member at both Duke University and the University of North Carolina at Chapel Hill. His work on this topic includes a recent book on misinformation and published studies in relation to misinformation and COVID-19 on connecting public understanding of other infectious diseases to the COVID-19 pandemic as well as evidence regarding COVID-19 vaccine hesitancy.
More on ncarol.com
To learn more about Dr. Southwell: https://www.rti.org/experts/expert-profiles/improving-society-bridging-gap-between-science-and-everyday-life
To set up an interview please contact [email protected]
SOURCE RTI International
Dr. Southwell has served as a key resource throughout the COVID-19 pandemic to help inform media outlets and the public on what misinformation is and how to address it. He has dedicated parts of his decades-long career to investigating the public understanding and misunderstanding of science, which has contributed to the spread of misinformation throughout the COVID-19 pandemic.
More on ncarol.com
- Kentucky's Plane Crash Data Lands Far from the State's Busiest Airports
- StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
- Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
- Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
- Heidi G. Villari of The Villari Firm, PLLC Recognized in The Best Lawyers in America 2027 for Construction Law and Personal Injury Litigation
Dr. Southwell is senior director of the Science in the Public Sphere program at RTI. He also serves as a faculty member at both Duke University and the University of North Carolina at Chapel Hill. His work on this topic includes a recent book on misinformation and published studies in relation to misinformation and COVID-19 on connecting public understanding of other infectious diseases to the COVID-19 pandemic as well as evidence regarding COVID-19 vaccine hesitancy.
More on ncarol.com
- When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
- Belmont, NC Emerges as More Than a Charlotte Alternative for Homebuyers
- Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
- RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
- Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History
To learn more about Dr. Southwell: https://www.rti.org/experts/expert-profiles/improving-society-bridging-gap-between-science-and-everyday-life
To set up an interview please contact [email protected]
SOURCE RTI International
0 Comments
Latest on ncarol.com
- LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
- The Sharon at SouthPark Breaks Ground on $178 Million Expansion
- Pattern Recognition In The Arts
- Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- Couture Master Perfumer JoAnne Bassett Unveils All-Natural Parfum in Oil Collection in Gift Box
- Independent Colbert Packaging Thrives Amid Industrywide Consolidation
- Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
- Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
- STEM For Kids® Unveil Turn-Key "Screen-Smart" Solution to Bridge Teacher Preparedness Gaps in Texas
- Award-Winning Couture Master Perfumer JoAnne Bassett Launches All-Natural DIY Perfume Making Kits
- Couture Master Perfumer JoAnne Bassett Offers Rare Opportunity to Acquire 70 Formula Perfume Codex
- Slotozilla Reports Strong Growth in Q2 2026
- Flexible Plan Investments Names Carl Resnick President
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
- No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
- The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
- Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)